Mild encephalopathy/encephalitis with a reversible splenial lesion (MERS): A report of five neonatal cases

Dan Sun1, Wen-Hong Chen2, Suraj Baralc3

  • 1Department of Pediatric Neurology, Wuhan Children's Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430016, China.

Insights

Mild encephalopathy/encephalitis with a reversible splenial (MERS) lesion is a rare condition in newborns. This study details five cases, highlighting rapid MRI lesion resolution and electrolyte imbalances, primarily hyponatremia, in affected neonates.

Area of Science:

  • Neurology
  • Pediatrics
  • Radiology

Background:

  • Mild encephalopathy/encephalitis with a reversible splenial (MERS) lesion is a clinic-radiological entity.
  • Clinical features of MERS in neonates are not well-documented.
  • This study presents five neonatal MERS cases and reviews existing literature.

Observation:

  • Five neonates (average age 4 days) presented with neurological symptoms like hyperspasmia, poor reactivity, and delirium.
  • Magnetic resonance imaging (MRI) revealed characteristic splenial lesions in the corpus callosum.
  • Lesions showed specific signal intensities on T1, T2, FLAIR, and DWI sequences with restricted diffusion.

Findings:

  • Splenial lesions on MRI resolved rapidly, often preceding clinical recovery.
  • All cases experienced electrolyte disturbances, notably hyponatremia, which was correctable.
  • Most neonates had signs of infection, normal electroencephalography (EEG), and recovered within 1-4 weeks.

Implications:

  • This study expands the understanding of MERS in neonates, a population with limited reported data.
  • The rapid MRI resolution and association with electrolyte imbalances, particularly hyponatremia, are key diagnostic features.
  • Findings suggest MERS is a distinct entity with a generally favorable prognosis in neonates, often linked to infection.

Related Concept Videos